Seocho, Seoul-t'ukpyolsi, South Korea The venture was found in Asia in South Korea. The main department of described VC is located in the Seocho.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Bass Investment, startups are often financed by KB Investment, Murex Partners, TL Asset Management. The meaningful sponsors for the fund in investment in the same round are Murex Partners, KB Investment, Dunamu & Partners. In the next rounds fund is usually obtained by Murex Partners, Shinhan Bank, DS Asset Management.
The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Employee Benefits, Enterprise Software. Among the various public portfolio startups of the fund, we may underline ImpriMed, Allganize, Swingvy Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The typical startup value when the investment from Bass Investment is 10-50 millions dollars. The top activity for fund was in 2019.
The overall number of key employees were 2.
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OFFLIGHT | 19 Mar 2024 | Seocho, Seoul-t'ukpyolsi, South Korea | |||
Ad-Shield | $2M | 19 Feb 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Doers | 26 Jan 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Four Pillars | $609K | 16 Jan 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
GPTers | 13 Dec 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
DOR | 07 Dec 2023 | South Korea, Gangwon-do, South Korea | |||
Medipal | $4M | 01 Nov 2023 | South Korea, Gangwon-do, South Korea | ||
Lerici | 27 Oct 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
CryptoQuant | $7M | 03 Jul 2023 | Seoul, Seoul-t'ukpyolsi, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OFFLIGHT | 19 Mar 2024 | Seocho, Seoul-t'ukpyolsi, South Korea | |||
Ad-Shield | $2M | 19 Feb 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Doers | 26 Jan 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Four Pillars | $609K | 16 Jan 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
GPTers | 13 Dec 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
DOR | 07 Dec 2023 | South Korea, Gangwon-do, South Korea | |||
Medipal | $4M | 01 Nov 2023 | South Korea, Gangwon-do, South Korea | ||
Lerici | 27 Oct 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
CryptoQuant | $7M | 03 Jul 2023 | Seoul, Seoul-t'ukpyolsi, South Korea |
